40. Andrabi, R., J. N. Bhiman, and D. R. Burton. “Strategies for a Multi-Stage Neutralizing Antibody-Based HIV Vaccine.”
41. Burton, D. R., and L. Hangartner. “Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.”
42. Walker, L. M., and D. R. Burton. “Rational Antibody-Based HIV-1 Vaccine Design: Current Approaches and Future Directions.”
43. Borrow, P., H. Lewicki, B. H. Hahn, G. M. Shaw, and M. B. Oldstone. “Virus-Specific CD8+ Cytotoxic T-Lymphocyte Activity Associated with Control of Viremia in Primary Human Immunodeficiency Virus Type 1 Infection.”
44. Walker, B. D., S. Chakrabati, B. Moss, T. J. Paradis, T. Flynn, A. G. Durno, R. S. Blumberg, J. C. Kaplan, M. S. Hirsch, and R. T. Schooley. “HIV Specific Cytotoxic T Lymphocytes in Seropositive Individuals.”
45. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, and B. H. Hahn. “Viral Dynamics in Human Immunodeficiency Virus Type 1 Infection.”
46. Fauci, A. “AIDS: Newer Concepts in the Immunopathogenic Mechanism of Human Immunodeficiency Virus Disease.”
47. Chun, T. W., J. S. Justement, P. Pandya, C. W. Hallahan, M. McLaughlin, S. Liu, L. A. Ehler, C. Kovacs, and A. S. Fauci. “Relationship Between the Size of the Human Immunodeficiency Virus Type 1 (HIV-1) Reservoir in Peripheral Blood CD4+ T Cells and CD4+:CD8+ T Cell Ratios in Aviremic HIV-1-Infected Individuals Receiving Long-Term Highly Active Antiretroviral Therapy.”
48. Chun, T. W., D. C. Nickle, J. S. Justement, J. H. Meyers, G. Roby, C. W. Hallahan, S. Kottilil, et al. “Persistence of HIV in Gut-Associated Lymphoid Tissue Despite Long-Term Antiretroviral Therapy.”
49. Guadalupe, M., E. Reay, S. Sankaran, T. Prindiville, J. Flamm, A. McNeil, and S. Dandekar. “Severe CD4+ T– Cell Depletion in Gut Lymphoid Tissue During Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration Following Highly Active Antiretroviral Therapy.”
50. Wiley, C., R. D. Schrier, J. A. Nelson, P. W. Lampert, and M. B. Oldstone. “Cellular Localization of Human Immunodeficiency Virus Infection Within the Brains of Acquired Immunodeficiency Syndrome Patients.”
51. Moses, A. V., and J. A. Nelson. “HIV Infection of Human Brain Capillary Endothelial Cells – Implications for AIDS Dementia.”
52. Pierson, T., J. McArthur, and R. F. Siliciano. “Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral Therapy.”
53. Le Gall, S., L. Erdtmann, S. Benichou, C. Berlioz-Torrent, L. Liu, R. Benarous, J. M. Heard, and O. Schwartz. “Nef Interacts with the Mu Subunit of Clathrin Adaptor Complexes and Reveals a Cryptic Sorting Signal in MHC 1 Molecules.”
54. Stumptner-Cuvelette, P., S. Morchoisne, M. Dugast, S. Le Gall, G. Raposo,O. Schwartz, and P. Benaroch. “HIV-1 Nef Impairs MHC Class II Antigen Presentation and Surface Expression.”
55. Yang, O. O., P. T. Nguyen, S. A. Kalams, T. Dorfman, H. G. Göttlinger, S. Stewart, I. S. Chen, S. Threlkeld, and B. D. Walker. “Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T Lymphocytes.”
56. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski. “The Antigenic Structure of the HIV gp120 Envelope Glycoprotein.”
57. Kwong, P. D., R. Wyatt, S. Majeed, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. “Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates.”
58. Haase, A. T., E. F. Retzel, and K. A. Staskus. “Amplification and Detection of Lentiviral DNA Inside Cells.”